Not Every Biopharma Team Needs Full Pharmacovigilance Outsourcing
In a recent industry discussion around partial pharmacovigilance outsourcing, one point stood out clearly: Not every biopharma company needs full pharmacovigilance outsourcing.And
SafeCue Industry Pulse 2026
Early Observations on ICSR Narrative Consistency and Inspection Defensibility ICSR narratives play a critical role in pharmacovigilance by providing the clinical context necessary
How to Handle Conflicting Source Documents (and Document It Correctly)
In pharmacovigilance, the source documents don’t always agree. A clinical narrative may conflict with a discharge summary. A lab report may contradict a progress note. An EDC ent
Inspection readiness doesn’t start when the auditor arrives.
Introducing the SafeCue PV Case Quality & Defensibility Assessment Pilot In today’s regulatory environment, inspection readiness is no longer just about meeting timelines—i
Why Periodic Case Quality Reviews Are Essential for Audit-Ready Pharmacovigilance
In pharmacovigilance, quality is not a one-time checkpoint, it is a continuous process. While Individual Case Safety Reports (ICSRs) may meet submission timelines, that does not al